A November 2024 systematic review of randomized controlled trials (RCTs) by the University of Oxford, published in the Annals of Internal Medicine reviewed studies of weight loss interventions and their impact on PCOS (polycystic ovary syndrome (PCOS). The review found that such interventions were “associated with greater reductions in glycemic control and hormonal markers including the free androgen index (FAI) and … indicate that weight loss interventions may be an effective tool for PCOS management in applied clinical settings, and clinicians could use these results to counsel patients with PCOS on the improvements in PCOS markers after weight loss and direct them towards appropriate interventions.” [Eurekalert.org]